Morgan Stanley’s Immuron IMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.8K | Sell |
1,700
-28,874
| -94% | -$28.8K | ﹤0.01% | 7427 |
|
|
2026
Q1 | $23.7K | Sell |
30,574
-26,807
| -47% | -$22.3K | ﹤0.01% | 6663 |
|
|
2025
Q4 | $43.8K | Buy |
57,381
+39,128
| +214% | +$64.5K | ﹤0.01% | 6479 |
|
|
2025
Q3 | $34.7K | Buy |
18,253
+17,553
| +2,508% | +$31.4K | ﹤0.01% | 6518 |
|
|
2025
Q2 | $1.22K | Buy |
+700
| New | +$1.25K | ﹤0.01% | 7312 |
|
|
2024
Q4 | – | Sell |
-3,333
| Closed | -$9.07K | – | 8027 |
|
|
2024
Q3 | $9.07K | Sell |
3,333
-1,658
| -33% | -$4.19K | ﹤0.01% | 6745 |
|
|
2024
Q2 | $12.1K | Buy |
4,991
+4,400
| +745% | +$10.7K | ﹤0.01% | 6616 |
|
|
2024
Q1 | $1.55K | Sell |
591
-7,191
| -92% | -$15.5K | ﹤0.01% | 7109 |
|
|
2023
Q4 | $14.6K | Buy |
7,782
+3,091
| +66% | +$5.71K | ﹤0.01% | 6749 |
|
|
2023
Q3 | $9.29K | Sell |
4,691
-2,155
| -31% | -$4.26K | ﹤0.01% | 6753 |
|
|
2023
Q2 | $13.8K | Buy |
6,846
+1,946
| +40% | +$4.01K | ﹤0.01% | 6687 |
|
|
2023
Q1 | $9.19K | Buy |
4,900
+500
| +11% | +$1.01K | ﹤0.01% | 6907 |
|
|
2022
Q4 | $9.15K | Buy |
4,400
+100
| +2% | +$200 | ﹤0.01% | 6974 |
|
|
2022
Q3 | $9K | Sell |
4,300
-280
| -6% | -$679 | ﹤0.01% | 7108 |
|
|
2022
Q2 | $10K | Sell |
4,580
-320
| -7% | -$911 | ﹤0.01% | 7204 |
|
|
2022
Q1 | $16K | Buy |
4,900
+3,197
| +188% | +$10.3K | ﹤0.01% | 7234 |
|
|
2021
Q4 | $4K | Sell |
1,703
-1,418
| -45% | -$4.78K | ﹤0.01% | 7688 |
|
|
2021
Q3 | $12K | Sell |
3,121
-18,800
| -86% | -$79.5K | ﹤0.01% | 7269 |
|
|
2021
Q2 | $106K | Sell |
21,921
-18,250
| -45% | -$97.8K | ﹤0.01% | 6332 |
|
|
2021
Q1 | $241K | Buy |
+40,171
| New | +$276K | ﹤0.01% | 5551 |
|
|
2020
Q4 | – | Sell |
-13,290
| Closed | -$100K | – | 7063 |
|
|
2020
Q3 | $100K | Buy |
+13,290
| New | +$120K | ﹤0.01% | 5438 |
|
|
2020
Q2 | – | Sell |
-2,726
| Closed | -$5K | – | 6654 |
|
|
2020
Q1 | $5K | Buy |
2,726
+457
| +20% | +$1.44K | ﹤0.01% | 6207 |
|
|
2019
Q4 | $8K | Buy |
2,269
+2,263
| +37,717% | +$7.84K | ﹤0.01% | 6313 |
|
|
2019
Q3 | $0 | Buy |
6
+4
| +200% | +$12 | ﹤0.01% | 6685 |
|
|
2019
Q2 | $0 | Sell |
2
-3
| -60% | -$14 | ﹤0.01% | 6687 |
|
|
2019
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 6634 |
|
|
2018
Q4 | $0 | Sell |
5
-5
| -50% | -$38 | ﹤0.01% | 6650 |
|
|
2018
Q3 | $0 | Sell |
10
-1
| -9% | -$10 | ﹤0.01% | 6746 |
|
|
2018
Q2 | $0 | Buy |
+11
| New | +$105 | ﹤0.01% | 6699 |
|
Other funds holding IMRN
Morgan Stanley's IMRN Position: Q2 2026 in Review
Morgan Stanley reduced its Immuron (IMRN) stake by 94% in Q2 2026, selling an estimated $28.8K and leaving 1,700 shares worth $1.8K. The position accounts for ﹤0.01% of the portfolio, ranked #7427.
Morgan Stanley first reported a position in IMRN in Q2 2018 and has held it in 29 quarters since. The position peaked at $241K in Q1 2021. 4 funds tracked by Wall St. Rank hold IMRN as of Q2 2026.
- Morgan Stanley held 1,700 shares of Immuron worth $1.8K as of Q2 2026.
- Morgan Stanley sold 28,874 Immuron shares in Q2 2026, an estimated $28.8K.
- Immuron made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7427 holding.
- Morgan Stanley first reported a position in Immuron in Q2 2018 and has held it in 29 quarters since.
- Morgan Stanley's Immuron position peaked at $241K in Q1 2021.
- 4 funds tracked by Wall St. Rank held Immuron as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.